Seaside Therapeutics was founded to translate promising research discoveries into effective treatments for patients with autism, fragile X syndrome and other disorders of brain development. Our vision is to successfully develop breakthrough medications that will meaningfully improve the lives of individuals with these disorders.
Company Details
- Employees
- 13
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Seaside Therapeutics Questions
Seaside Therapeutics's website is http://www.seasidetherapeutics.com
Seaside Therapeutics's LinkedIn profile is https://www.linkedin.com/company/seaside-therapeutics
Seaside Therapeutics has
13 employees.
View email and phone details for 13
employees at Seaside Therapeutics.
Seaside Therapeutics's industry is
Biotechnology Research
Seaside Therapeutics's top competitors are
Zynerba Pharmaceuticals,
Curemark®,
Alcobra,
Curemark, Llc,
Sentinel Oncology Limited,
Cellceutix Corporation,
Marvel Biosciences Corp.,
Actinogen Medical,
Pace® Life Sciences,
Axial Therapeutics, Inc..
Seaside Therapeutics's categories are Biotechnology Research
Seaside Therapeutics's founding year is 2005
